Abstract
Molecular and cellular requirements for antigen-specific isotype switch of human B cells have been investigated by mimicking signaling occurring in germinal centers. Peripheral blood mononuclear cells from healthy seronegative blood donors were first primary immunized in vitro, using a synthetic immunogen containing both a T and B cell epitope, which generated specific IgM-secreting B cells. We used the apex of the V3 loop of gp120 as B cell epitope linked to a promiscuous T helper epitope from tetanus toxin. In parallel, CD4+ T helper cell clones specific for the T epitope of the immunogen were established. In a secondary in vitro stimulation period, we co-cultured the antigen-specific T and B cells on CD32-transfected fibroblasts, together with an anti-CD40 monoclonal antibody. This resulted in isotype switching and human antigen-specific, IgG-secreting B cells were detected. This response was strictly dependent upon the presence of autologous T helper cells and the immunogen. Antigen-specific human B cells derived from this primary and secondary in vitro immunization were subsequently subjected to electrofield-induced somatic cell hybridization and hybridomas secreting human anti-V3 IgG monoclonal antibodies were isolated. O...Continue Reading
References
Jun 1, 1992·Bio/technology·C A BorrebaeckM Ohlin
Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·F RoussetJ Banchereau
Jul 31, 1992·Journal of Immunological Methods·P G SteenbakkersW Olijve
Jul 1, 1991·Immunology Today·S Mallett, A N Barclay
Oct 11, 1991·Science·P SalgameB R Bloom
Jan 4, 1991·Science·J BanchereauF Rousset
Oct 17, 1991·Nature·J Banchereau, F Rousset
Jan 1, 1992·Immunology Today·Y J LiuI C MacLennan
Jan 1, 1990·Current Topics in Microbiology and Immunology·I C MacLennanP J Lane
Dec 12, 1986·Science·S D PutneyK J Weinhold
Nov 1, 1988·Immunology Today·C A Borrebaeck
May 1, 1986·Journal of Immunological Methods·W L CarrollR Levy
Jun 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·C A BorrebaeckS A Möller
Jan 29, 1993·Cell·A AruffoM Neubauer
Feb 12, 1993·Science·R C AllenD K Simoneaux
Sep 1, 1993·The Journal of Experimental Medicine·S NonoyamaH D Ochs
Nov 1, 1994·Scandinavian Journal of Immunology·L T ChinC A Borrebaeck
Feb 11, 1993·Nature·J P DiSantoG de Saint Basile
Jun 1, 1993·Current Opinion in Immunology·G Kelsoe, B Zheng
Citations
Apr 20, 2004·Toxicology Letters·Danuta J Herzyk, Elizabeth R Gore
Jan 15, 1997·Journal of Immunological Methods·A ZafiropoulosC A Borrebaeck
Mar 22, 2002·Allergy·A AkessonC A K Borrebaeck
Sep 6, 2000·The Biochemical Journal·K BradyP N Moynagh
Sep 1, 1996·Immunology·M DueñasC A Borrebaeck
Aug 4, 1998·The Journal of Experimental Medicine·E J MessikaM M Davis
Oct 12, 2011·The Journal of Experimental Medicine·Hua-Xin LiaoBarton F Haynes
Aug 24, 2007·BMC Biotechnology·Li-Te ChinChi-Hong Chu
Nov 16, 2001·Biochemical and Biophysical Research Communications·K BradyP N Moynagh
Aug 21, 2010·Journal of Immunological Methods·Ren-Jeh LeeHan-Min Chen
Jan 1, 1996·Acta Oncologica·M Alfonso, J Zeuthen
Feb 6, 2017·Experimental Cell Research·Xu FangWenbing Yao
Sep 6, 2000·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·A AkessonC A Borrebaeck
Dec 21, 2018·MAbs·Yue TongWenbing Yao
Apr 30, 2003·Cancer Gene Therapy·Lars H LundGösta Winberg
Apr 1, 1999·Human & Experimental Toxicology·R D Combes, L K Earl